Baidu
map

骨科指南

订阅

MedSci主页 / 所有栏目 / 骨科指南

2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理

2020-01-25 美国风湿病学会 Otolaryngol Head Neck Surg. 2020 Jan;162(1_suppl):

骨关节炎

2020年1月，美国风湿病学会(ACR)联合关节炎基金会(AF)共同发布了手、髋和膝关节骨关节炎的管理指南，该指南是对2012年ACR手、髋和膝关节骨关节炎的管理建议的更新，主要为临床医生和患者制定骨关节炎治疗决策时提供指导。

中文标题：

2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理

英文标题：

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.

发布机构：

美国风湿病学会

发布日期：

2020-01-25

简要介绍：

2020年1月，美国风湿病学会(ACR)联合关节炎基金会(AF)共同发布了手、髋和膝关节骨关节炎的管理指南，该指南是对2012年ACR手、髋和膝关节骨关节炎的管理建议的更新，主要为临床医生和患者制定骨关节炎治疗决策时提供指导。

 

拓展指南：与骨关节炎相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理)] GetToolGuiderByIdResponse(projectId=1, id=a156c1c00185a0c7, title=2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理, enTitle=2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee., guiderFrom=Otolaryngol Head Neck Surg. 2020 Jan;162(1_suppl):, authorId=null, author=, summary=2020年1月，美国风湿病学会(ACR)联合关节炎基金会(AF)共同发布了手、髋和膝关节骨关节炎的管理指南，该指南是对2012年ACR手、髋和膝关节骨关节炎的管理建议的更新，主要为临床医生和患者制定骨关节炎治疗决策时提供指导。 , cover=, journalId=null, articlesId=null, associationId=528, associationName=美国风湿病学会, associationIntro=The American College of Rheumatology&#039;s mission is advancing rheumatology. The organization is for physicians, health professionals, and scientists that meets the mission through programs of education, research, advocacy and practice support. The ACR provides professional education for its members through several venues. The Annual Scientific Meeting, held each fall, is the premier scientific meeting devoted to the rheumatic diseases. This meeting draws thousands of rheumatologists and arthritis health professionals from around the world. A winter rheumatology symposium, spring clinical meetings, and other topical conferences round out the ACR&#039;s educational offerings., copyright=0, guiderPublishedTime=Sat Jan 25 21:23:35 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月，美国风湿病学会(ACR)联合关节炎基金会(AF)共同发布了手、髋和膝关节骨关节炎的管理指南，该指南是对2012年ACR手、髋和膝关节骨关节炎的管理建议的更新，主要为临床医生和患者制定骨关节炎治疗决策时提供指导。 </P> <P> </P>拓展指南：<strong>与<font color=red>骨关节炎</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=af71a1c001800946" title="《骨关节炎诊疗指南（2018年版）》膝关节骨关节炎部分的更新与解读" target=_blank>《骨关节炎诊疗指南（2018年版）》膝关节骨关节炎部分的更新与解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c67ca1c001e8832d" title="2019 ESCEO专家共识：肠道菌群和骨关节炎管理" target=_blank>2019 ESCEO专家共识：肠道菌群和骨关节炎管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=792bd1c001e78618" title="2019 AAC立场声明：膝关节骨关节炎关节内注射" target=_blank>2019 AAC立场声明：膝关节骨关节炎关节内注射</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=793c21c001e607fe" title="2019 OARSI指南：膝关节、髋关节和多关节骨关节炎的非手术治疗" target=_blank>2019 OARSI指南：膝关节、髋关节和多关节骨关节炎的非手术治疗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=39c961c001e3272f" title="膝骨关节炎阶梯治疗专家共识（2018 年版）" target=_blank>膝骨关节炎阶梯治疗专家共识（2018 年版）</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E9%AA%A8%E5%85%B3%E8%8A%82%E7%82%8E" target=_blank>有关骨关节炎更多指南</a></ul>, tagList=[TagDto(tagId=210, tagName=骨关节炎)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=20567, appHits=331, showAppHits=16, pcHits=2966, showPcHits=19228, likes=54, shares=9, comments=11, approvalStatus=1, publishedTime=Sat Jan 25 21:23:35 CST 2020, publishedTimeString=2020-01-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Jan 25 21:23:35 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 20:26:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理)])
2019 ACR/AF指南：手、髋和膝关节骨关节炎的管理
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051893, encodeId=f46a105189345, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:38:25 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964138, encodeId=1be796413802, content=好用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe55495376, createdName=小凡凡, createdTime=Mon May 10 00:03:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944360, encodeId=0ecc94436017, content=谢谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7e5464135, createdName=李大大。, createdTime=Mon Mar 01 10:06:24 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945916, encodeId=52ac94591640, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:46 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945915, encodeId=91299459156a, content=还行, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:21 CST 2021, time=2021-03-06, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051893, encodeId=f46a105189345, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:38:25 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964138, encodeId=1be796413802, content=好用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe55495376, createdName=小凡凡, createdTime=Mon May 10 00:03:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944360, encodeId=0ecc94436017, content=谢谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7e5464135, createdName=李大大。, createdTime=Mon Mar 01 10:06:24 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945916, encodeId=52ac94591640, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:46 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945915, encodeId=91299459156a, content=还行, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:21 CST 2021, time=2021-03-06, status=1, ipAttribution=)]
    2021-05-10 小凡凡

    好用，谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051893, encodeId=f46a105189345, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:38:25 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964138, encodeId=1be796413802, content=好用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe55495376, createdName=小凡凡, createdTime=Mon May 10 00:03:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944360, encodeId=0ecc94436017, content=谢谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7e5464135, createdName=李大大。, createdTime=Mon Mar 01 10:06:24 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945916, encodeId=52ac94591640, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:46 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945915, encodeId=91299459156a, content=还行, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:21 CST 2021, time=2021-03-06, status=1, ipAttribution=)]
    2021-03-01 李大大。

    谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051893, encodeId=f46a105189345, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:38:25 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964138, encodeId=1be796413802, content=好用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe55495376, createdName=小凡凡, createdTime=Mon May 10 00:03:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944360, encodeId=0ecc94436017, content=谢谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7e5464135, createdName=李大大。, createdTime=Mon Mar 01 10:06:24 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945916, encodeId=52ac94591640, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:46 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945915, encodeId=91299459156a, content=还行, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:21 CST 2021, time=2021-03-06, status=1, ipAttribution=)]
    2021-03-06 ms9000001449441545

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1051893, encodeId=f46a105189345, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:38:25 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964138, encodeId=1be796413802, content=好用，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe55495376, createdName=小凡凡, createdTime=Mon May 10 00:03:12 CST 2021, time=2021-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944360, encodeId=0ecc94436017, content=谢谢 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b7e5464135, createdName=李大大。, createdTime=Mon Mar 01 10:06:24 CST 2021, time=2021-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945916, encodeId=52ac94591640, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:46 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=945915, encodeId=91299459156a, content=还行, beContent=null, objectType=guider, channel=null, level=null, likeNumber=144, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/a022fce6f74948b881e6b1b919083035/d0dcca4e59e54d9fb765a1b42b958387.jpg, createdBy=6a685466084, createdName=ms9000001449441545, createdTime=Sat Mar 06 09:20:21 CST 2021, time=2021-03-06, status=1, ipAttribution=)]
    2021-03-06 ms9000001449441545

    还行

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

《骨关节炎诊疗指南（2018年版）》膝关节骨关节炎部分的更新与解读

暂未更新 · 2019-09-30

2019 ESCEO专家共识：肠道菌群和骨关节炎管理

欧洲骨质疏松和骨关节炎临床经济学会(ESCEO,The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis) · 2019-08-19

2018 EULAR建议：炎性关节炎与骨关节炎患者的体力活动

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2018-07-11

2018 EULAR建议：炎性关节炎和骨关节炎患者疼痛的管理

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2018-05-03

2014 NICE 177 骨关节炎：成人护理及管理指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2014-02-12

2014 OARSI 膝骨关节炎非手术治疗指南

国际骨关节炎研究协会(OARSI,Osteoarthritis Research Society International) · 2014-01-23

Baidu
map
Baidu
map
Baidu
map